Torrent Pharmaceuticals has informed that a meeting of the Board of Directors will be held on Thursday, 30-Jul-26, to consider and approve the Unaudited Standalone and Consolidated Financial Results (with limited review) for the quarter ended on 30-Jun-26.
The above information is a part of company’s filings submitted to BSE.